cTRL Therapeutics Appoints Ruben Rodriguez, Ph.D., as Head of Research

SAN FRANCISCO, Dec. 12, 2023 -- (Healthcare Sales & Marketing Network) -- cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes (cTRLs) in the blood to broaden the power and reach of solid tumor cell therapy, today a... Biopharmaceuticals, Oncology, Personnel cTRL Therapeutics, circulating tumor-reactive lymphocytes
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news